C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@@]43C)C1CC[C@@H]2NC(=O)CCC(=O)O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?